QuidelOrtho Corp

QDEL remains under pressure, trading below its declining 200-day SMA with medium-term distribution evident under the 20-day EMA and capped by the 50-day SMA. Short-term action is neutral around the converged 9/20-day EMA cluster, offering no clear entry signal. Execution is deferred, looking to trim into rallies toward these moving-average resistance levels.

• ↑2.8% stock rise post-ADLM showcase highlights diagnostic innovation
• ↑New York strategic investment underscores institutional confidence
• ↓Negative earnings yield indicates severe profit pressure